AI assistant
J.B. Chemicals & Pharmaceuticals Lt — Call Transcript 2025
Feb 5, 2025
63696_rns_2025-02-05_76994c9b-219d-41ce-b634-249ac6d0b3f7.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [596 x 140] intentionally omitted <==
February 5, 2025
BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001
BSE Scrip Code: 506943
Stock Symbol: JBCHEPHARM
Dear Sir,
Subject: Audio recording of Investors/analysts call with Management
Ref.: Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 read with Schedule III and Regulation 46(2)(oa) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the conference call for investors and analysts scheduled on February 5, 2025 at 12.00 noon IST in relation to results and developments for the third quarter ended December 31, 2024 is available on the website of the Company.
The link to access the same is: https://jbpharma.com/download/q3-fy25-earnings-callaudio/?wpdmdl=10220&refresh=67a3298d4ae681738746253
We request you to take this on record.
Thanking you,
Yours faithfully,
For J.B. Chemicals & Pharmaceuticals Limited
Sandeep Phadnis Sandeep Anil Phadnis Digitally signed by Sandeep Anil Phadnis DN: c=IN, o=Personal, title=8434, pseudonym=108F69E4E868E4C1147674C13B2684AC9CDD8E36, 2.5.4.20=715f7603f235e5d1d74002aec03d24cf432efd8296e6e1c3c0c80534a90c098e, postalCode=411038, st=Maharashtra, serialNumber=CC500FDD638E71336FC58B204E2BA05EA7C4ADE49B8FE438E8F254C300DEC735, cn=Sandeep Anil Phadnis Date: 2025.02.05 14:40:01 +05'30' Vice President – Secretarial & Company Secretary
==> picture [595 x 154] intentionally omitted <==